CADLX | PCLNX | CADLX / PCLNX | |
Total Expense Ratio | 0.77 | 0.98 | 79% |
Annual Report Gross Expense Ratio | 0.77 | 1.20 | 64% |
Fund Existence | 11 years | 7 years | - |
Gain YTD | 2.391 | -4.296 | -56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 242M | 4.68B | 5% |
Annual Yield % from dividends | 7.90 | 8.16 | 97% |
Returns for 1 year | 2.14 | -6.39 | -34% |
Returns for 3 years | -10.36 | -3.90 | 266% |
Returns for 5 years | 92.32 | 157.87 | 58% |
Returns for 10 years | 30.72 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PPH | 82.01 | 1.73 | +2.15% |
VanEck Pharmaceutical ETF | |||
SPD | 33.85 | 0.65 | +1.96% |
Simplify US Equity PLUS Dwnsd Cnvxty ETF | |||
UCC | 35.30 | 0.66 | +1.91% |
ProShares Ultra Consumer Discretionary | |||
FIXD | 42.97 | -0.06 | -0.14% |
First Trust TCWOpportunistic Fxd Inc ETF | |||
WIA | 8.06 | -0.03 | -0.37% |
Western Asset Inflation-Linked Income Fund |